Kester Capital appeared to be the VC, which was created in 2007. The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the London.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Kester Capital, startups are often financed by The Still River Fund, HealthCare Ventures, Yasuda Enterprise Development. The meaningful sponsors for the fund in investment in the same round are Yasuda Enterprise Development, The Still River Fund, Neomed Management. In the next rounds fund is usually obtained by GTCR, Fosun Group.
Among the most popular portfolio startups of the fund, we may highlight Xanthus Pharmaceuticals. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Association. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Besides them, we counted 4 critical employees of this fund in our database.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2006. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 66 percentage points more often commits exit comparing to other organizations. This Kester Capital works on 28 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2008.
Related Funds
Fund Name | Location |
Capria Ventures | Seattle, United States, Washington |
Fibrotic Ventures | Atlanta, Georgia, United States |
Frazier Technology Ventures | Seattle, United States, Washington |
Garuda Ventures | California, San Francisco, United States |
Geo-Jade Petroleum | Beijing, Beijing, China |
Haiheng capital | - |
IdeaEdge Ventures | California, San Diego, United States |
Nirvana Venture Advisors | India, Maharashtra, Mumbai |
S-Kap Unternehmensbeteiligungs | Baden-Wurttemberg, Germany, Pforzheim |
Shanghai Decun Touzi Youxian Gongsi | China, Shanghai |
SORACOM | Japan, Tokyo |
Taaleri | Finland, Helsinki, Southern Finland |
TechFounders | Bayern, Germany, Munich |
Tickets.com | California, Costa Mesa, United States |
Toyota Tunas | - |
Zhanrui Xinfu Equity Investment Fund Management | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Xanthus Pharmaceuticals | $25M | 01 Dec 2006 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Xanthus Pharmaceuticals | $25M | 01 Dec 2006 | Cambridge, Massachusetts, United States |